Cargando…

Rewriting the rules for care of MDS and AML patients in the time of COVID-19

The care of patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) has been radically altered by COVID-19, especially in New York City, the epicenter of the pandemic. Here we summarize how telemedicine, virtual visits, delayed transfusions, and chemotherapy, preferably select...

Descripción completa

Detalles Bibliográficos
Autores principales: Raza, Azra, Assal, Amer, Ali, Abdullah M., Jurcic, Joseph G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169905/
https://www.ncbi.nlm.nih.gov/pubmed/32318330
http://dx.doi.org/10.1016/j.lrr.2020.100201
_version_ 1783523814947160064
author Raza, Azra
Assal, Amer
Ali, Abdullah M.
Jurcic, Joseph G.
author_facet Raza, Azra
Assal, Amer
Ali, Abdullah M.
Jurcic, Joseph G.
author_sort Raza, Azra
collection PubMed
description The care of patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) has been radically altered by COVID-19, especially in New York City, the epicenter of the pandemic. Here we summarize how telemedicine, virtual visits, delayed transfusions, and chemotherapy, preferably selecting self-administered medications and visits by home healthcare workers, are employed to minimize exposure of our high-risk population of patients to the virus. The unique challenges of transplants during the pandemic and the consequences of an abrupt halt in all non-essential research activities are described. Not all the changes forced by COVID-19 are detrimental.
format Online
Article
Text
id pubmed-7169905
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-71699052020-05-05 Rewriting the rules for care of MDS and AML patients in the time of COVID-19 Raza, Azra Assal, Amer Ali, Abdullah M. Jurcic, Joseph G. Leuk Res Rep Article The care of patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) has been radically altered by COVID-19, especially in New York City, the epicenter of the pandemic. Here we summarize how telemedicine, virtual visits, delayed transfusions, and chemotherapy, preferably selecting self-administered medications and visits by home healthcare workers, are employed to minimize exposure of our high-risk population of patients to the virus. The unique challenges of transplants during the pandemic and the consequences of an abrupt halt in all non-essential research activities are described. Not all the changes forced by COVID-19 are detrimental. Elsevier 2020-04-20 /pmc/articles/PMC7169905/ /pubmed/32318330 http://dx.doi.org/10.1016/j.lrr.2020.100201 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Raza, Azra
Assal, Amer
Ali, Abdullah M.
Jurcic, Joseph G.
Rewriting the rules for care of MDS and AML patients in the time of COVID-19
title Rewriting the rules for care of MDS and AML patients in the time of COVID-19
title_full Rewriting the rules for care of MDS and AML patients in the time of COVID-19
title_fullStr Rewriting the rules for care of MDS and AML patients in the time of COVID-19
title_full_unstemmed Rewriting the rules for care of MDS and AML patients in the time of COVID-19
title_short Rewriting the rules for care of MDS and AML patients in the time of COVID-19
title_sort rewriting the rules for care of mds and aml patients in the time of covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169905/
https://www.ncbi.nlm.nih.gov/pubmed/32318330
http://dx.doi.org/10.1016/j.lrr.2020.100201
work_keys_str_mv AT razaazra rewritingtherulesforcareofmdsandamlpatientsinthetimeofcovid19
AT assalamer rewritingtherulesforcareofmdsandamlpatientsinthetimeofcovid19
AT aliabdullahm rewritingtherulesforcareofmdsandamlpatientsinthetimeofcovid19
AT jurcicjosephg rewritingtherulesforcareofmdsandamlpatientsinthetimeofcovid19